Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220356 · ClinicalTrials.gov registry record · Phase 4
C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics
A Phase 4 study of Tobacco Dependence, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07220356: Recruiting Phase 4 study of Tobacco Dependence, sponsored by Johns Hopkins University.
NCT07220356 is a Phase 4 study of Tobacco Dependence that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 30 participants, below the 478-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07220356, a Phase 4 study of Tobacco Dependence, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
In a residency clinic in Baltimore, the investigators propose to conduct a pilot RCT comparing a) an avatar-delivered computerized intervention (CI) for tobacco cessation augmented with CHW support and navigation to lung cancer screening to b) a waitlist control. With a sample of participants from the residency clinic (N=30), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month, 3 months, and 6 months. The investigators will conduct interviews with a subset of pilot participants to collect qualitative data on intervention acceptability.
Conditions Studied
Interventions
- OTHER Community Health Worker
- DRUG Nicotine Replacement Product
- BEHAVIORAL C-Raven Virtual Tobacco Cessation Counseling
- OTHER Lung Cancer Screening
Study Locations (1)
Maryland
- Johns Hopkins University School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-12-10 |
| Est. Completion | 2027-06-30 |
| Phase | Phase 4 |
What NCT07220356 shows while recruiting
NCT07220356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 478-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 4 interventions - of which Community Health Worker is the first listed.
NCT07220356 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT07220356 about?
NCT07220356 is a clinical study titled "C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics". In a residency clinic in Baltimore, the investigators propose to conduct a pilot RCT comparing a) an avatar-delivered computerized intervention (CI) for tobacco cessation augmented with CHW support and navigation to lung cancer screening to b) a waitlist control. With a sample of participants from ...
What is the current status of trial NCT07220356?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2025-12-10. Estimated completion is 2027-06-30.
What conditions does trial NCT07220356 study?
This clinical trial studies the following conditions: Tobacco Dependence.
What interventions are being tested in trial NCT07220356?
The interventions under investigation include: Community Health Worker (OTHER), Nicotine Replacement Product (DRUG), C-Raven Virtual Tobacco Cessation Counseling (BEHAVIORAL), Lung Cancer Screening (OTHER).
Who is sponsoring clinical trial NCT07220356?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07220356 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07220356's enrollment target sits among peer trials
30 28th of 28 higher than 1 of 28 other Tobacco Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
RECRUITING · Phase 4
-
C-Raven, a Virtual Tobacco Cessation Intervention in the Community
COMPLETED · Phase 4
-
Bupropion SR Plus Counseling for Smoking Cessation
COMPLETED · Phase 4
-
Varenicline OTC Trial on Efficacy and Safety
COMPLETED · Phase 4
-
Harm Reduction for Smokers With Mental Illness
RECRUITING · NA
-
Cannabidiol for Reducing Cigarette Use
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI